RecallHawk

AMPICILLIN (AMPICILLIN SODIUM)

EUGIA PHARMA SPECLTS

Summary

FDA approved AMPICILLIN (AMPICILLIN SODIUM) by EUGIA PHARMA SPECLTS. ANDA (Generic) approval (Labeling) on 2024-05-01. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

ANDA065499-13

Action Date

2024-05-01

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

AMPICILLIN (generic: AMPICILLIN SODIUM), INJECTABLE, INJECTION. Application: ANDA065499

Context & Analysis

EUGIA PHARMA SPECLTS has 4 FDA actions in our database.

Frequently Asked Questions

How often does EUGIA PHARMA SPECLTS have FDA actions?

EUGIA PHARMA SPECLTS has 4 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA065499-13" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions